76 related articles for article (PubMed ID: 11522034)
21. A randomized trial comparing 1 mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves.
Ageno W; Garcia D; Silingardi M; Galli M; Crowther M
J Am Coll Cardiol; 2005 Aug; 46(4):732-3. PubMed ID: 16098445
[No Abstract] [Full Text] [Related]
22. Letter regarding article by Hylek et al, "Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation".
Ono A; Kawamura I; Fujita T
Circulation; 2007 Nov; 116(20):e538. PubMed ID: 17998467
[No Abstract] [Full Text] [Related]
23. [Prothrombin complex concentrate good in warfarin induced hemorrhage. Quick reversal--plasma should be avoided].
Själander A; Berntorp E; Svensson PJ
Lakartidningen; 2009 Sep 9-15; 106(37):2278, 2280-1. PubMed ID: 19817161
[No Abstract] [Full Text] [Related]
24. Low-dose vitamin K to augment anticoagulation control.
Reese AM; Farnett LE; Lyons RM; Patel B; Morgan L; Bussey HI
Pharmacotherapy; 2005 Dec; 25(12):1746-51. PubMed ID: 16305294
[TBL] [Abstract][Full Text] [Related]
25. Consistent vitamin K helps warfarin do its job. Food can throw off warfarin's ability to prevent blood clots. Keeping your vitamin K intake relatively constant can help you avoid problems with this medication.
Harv Heart Lett; 2004 Sep; 15(1):4. PubMed ID: 15381495
[No Abstract] [Full Text] [Related]
26. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Hylek EM
Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
[No Abstract] [Full Text] [Related]
27. [Vitamin K in food and the effect of warfarin].
Melien Ø; Johansen PW; Westergren T; Rugstad HE
Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1862-3. PubMed ID: 12830268
[No Abstract] [Full Text] [Related]
28. Should I follow a special diet while taking warfarin?
Mayo Clin Womens Healthsource; 2005 Dec; 9(12):10. PubMed ID: 16301990
[No Abstract] [Full Text] [Related]
29. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?
Perez-Gomez F
Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377
[No Abstract] [Full Text] [Related]
30. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
[TBL] [Abstract][Full Text] [Related]
31. Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.
Crowther MA; Ageno W; Schnurr T; Manfredi E; Kinnon K; Garcia D; Douketis JD
Haematologica; 2005 Jan; 90(1):137-9. PubMed ID: 15642685
[TBL] [Abstract][Full Text] [Related]
32. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.
Jacobs LG
Cardiol Clin; 2008 May; 26(2):157-67, v. PubMed ID: 18406992
[TBL] [Abstract][Full Text] [Related]
33. Warfarin for atrial fibrillation.
Sidhu J; Oakeshott P
Br J Gen Pract; 2006 Nov; 56(532):886. PubMed ID: 17132363
[No Abstract] [Full Text] [Related]
34. Prevention of stroke in patients with atrial fibrillation.
Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
[No Abstract] [Full Text] [Related]
35. [New international guidelines on antithrombotic therapy in atrial fibrillation].
Tveit A
Tidsskr Nor Laegeforen; 2009 Jun; 129(13):1332-5. PubMed ID: 19561659
[TBL] [Abstract][Full Text] [Related]
36. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
Mant JW
Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
[No Abstract] [Full Text] [Related]
37. Life-threatening bleeding in a patient with a lupus inhibitor and probable acquired factor VII deficiency.
Lim S; Zuha R; Burt T; Chacko J; Scott R; Mainwaring CJ
Blood Coagul Fibrinolysis; 2006 Nov; 17(8):667-71. PubMed ID: 17102654
[TBL] [Abstract][Full Text] [Related]
38. New anticoagulants for atrial fibrillation.
De Caterina R; Kristensen SD; Renda G
J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
[TBL] [Abstract][Full Text] [Related]
39. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
[TBL] [Abstract][Full Text] [Related]
40. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Selçuk H; Selçuk MT; Maden O
Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
